Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01243606 · ClinicalTrials.gov registry record · NA
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
A NA study of Anxiety Disorders and Mood Disorders, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT01243606 is a NA study of Anxiety Disorders and Mood Disorders that has completed, run by Boston University Charles River Campus. The registered enrollment target is 250 participants, below the 1,137-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01243606, a NA study of Anxiety Disorders and Mood Disorders, has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
Anxiety disorders are common, chronic, costly, debilitating to quality of life, and are more prevalent than any other class of disorders in every country in the world where surveys have been taken. Deepening understanding of the nature of anxiety and related emotional disorders during the last decade has revealed that commonalities in etiology and latent structure among these disorders supersedes differences. At the same time, examination of extant single diagnosis psychological treatment protocols (SDPs) for these disorders underscores mechanistic similarities. These findings suggested the possibility of distilling a set of psychological procedures that would comprise an innovative Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP), and this protocol has now been developed. If efficacious, the UP may represent a more efficient and possibly more effective strategy which would render treatment implications of comorbidity, not otherwise specified (NOS) and subdefinitional threshold anxiety disorder conditions moot. The investigators now propose an evaluation of the efficacy of the UP in a group of patients with heterogeneous anxiety disorders by way of rigorous comparisons to existing evidence based SDPs benchmarked against a wait list control condition, using both statistical equivalence and superiority analyses. Additional aims include determining the durability of the UP relative to comparison conditions after treatment discontinuation, and ascertaining the differential impact of treatments on disorder specific symptoms vs. higher-order temperamental variables. Further analyses will indicate if changes in these higher order temperamental variables mediate long-term outcome as preliminary data suggests, and if this mechanism of action differs among treatments.
Conditions Studied
Interventions
- BEHAVIORAL Single Diagnosis Treatment Protocol
- BEHAVIORAL Unified Protocol (UP)
Study Locations (1)
Massachusetts
- Center for Anxiety and Related Disorders at Boston University - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2010-12 |
| Est. Completion | 2017-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01243606
The ClinicalTrials.gov registry entry for NCT01243606 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,137-participant average among 84 other Anxiety Disorders trials with a reported enrollment target (78% lower). The listed sponsor is Boston University Charles River Campus, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Anxiety Disorders appearing as the primary indexed condition, and to 2 interventions - of which Single Diagnosis Treatment Protocol is the first listed.
NCT01243606 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01243606 about?
NCT01243606 is a clinical study titled "Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders". Anxiety disorders are common, chronic, costly, debilitating to quality of life, and are more prevalent than any other class of disorders in every country in the world where surveys have been taken. Deepening understanding of the nature of anxiety and related emotional disorders during the last decad...
What is the current status of trial NCT01243606?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2010-12. Estimated completion is 2017-05.
What conditions does trial NCT01243606 study?
This clinical trial studies the following conditions: Anxiety Disorders, Mood Disorders.
What interventions are being tested in trial NCT01243606?
The interventions under investigation include: Single Diagnosis Treatment Protocol (BEHAVIORAL), Unified Protocol (UP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01243606?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01243606 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
Initial Assessment of the Feasibility and Efficacy of a Scalable Digital CBT for Generalized Anxiety and Associated Health Behaviors in a Cardiovascular Disease Population
RECRUITING · NA
-
Managing Anxiety in Pediatric Primary Care (MAPP)
RECRUITING · NA
-
DINO RCT - Treating Anxiety in Children With Autism
RECRUITING · NA
-
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.